Scientific article
French

[Rituximab-induced acute thrombocytopenia in a patient with chronic lymphocytic leukemia]

Published in

La Revue de médecine interne, vol. 38, no. 5, p. 344-346

Publication date

2017

Abstract

Rituximab is a chimeric anti-CD20 monoclonal antibody generally well tolerated. However, a severe but rare rituximab-related immune-toxic syndrome, associating fever, chills and thrombocytopenia can occur shortly after the infusion.

Citation (ISO format)

BOBOT, M et al. [Rituximab-induced acute thrombocytopenia in a patient with chronic lymphocytic leukemia]. In: La Revue de médecine interne, 2017, vol. 38, n° 5, p. 344–346. doi: 10.1016/j.revmed.2016.08.008

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0248-8663
417views
0downloads

Technical informations

Creation

09/11/2016 12:18:00

First validation

09/11/2016 12:18:00

Update

15/03/2023 01:04:27

Status update

15/03/2023 01:04:26

Last indexation

31/10/2024 05:22:47
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated